5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma.

      1 , 2 , 3 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 9 , 19 , 20 , 21 , 22 , 23 , 24 , 8 , 5 , 21 , 19 , 25 , 12 , 4 , 26 , 14 , 27 , 20 , 28 , 11 , 24 , 26 , 8 , 29 , 27 , 30 , 31 , 32 , 21 , 30 , 18 , 12 , 33 , 34 , 14 , 35 , 4 , 22 , 22 , 36 , 37 , 24 , 38 , 4 , 27 , 39 , 34 , 18 , 40 , 33 , 41 , 36 , 12 , 39 , 34 , 42 , 43 , 43 , 26 , 23 , 43 , 44 , 37 , 31 , 11 , 7 , 37 , 20 , 32 , 32 , 13 , 36 , 22 , 42 , 20 , 21 , 42 , 9 , 33 , 35
      Journal of lipid research
      American Society for Biochemistry & Molecular Biology (ASBMB)
      National Institute of Standards and Technology, Standard Reference Material 1950, fatty acyls, glycerolipids, lipids, phospholipids, quality control, quantitation, sphingolipids, sterols

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          As the lipidomics field continues to advance, self-evaluation within the community is critical. Here, we performed an interlaboratory comparison exercise for lipidomics using Standard Reference Material (SRM) 1950-Metabolites in Frozen Human Plasma, a commercially available reference material. The interlaboratory study comprised 31 diverse laboratories, with each laboratory using a different lipidomics workflow. A total of 1,527 unique lipids were measured across all laboratories and consensus location estimates and associated uncertainties were determined for 339 of these lipids measured at the sum composition level by five or more participating laboratories. These evaluated lipids detected in SRM 1950 serve as community-wide benchmarks for intra- and interlaboratory quality control and method validation. These analyses were performed using nonstandardized laboratory-independent workflows. The consensus locations were also compared with a previous examination of SRM 1950 by the LIPID MAPS consortium. While the central theme of the interlaboratory study was to provide values to help harmonize lipids, lipid mediators, and precursor measurements across the community, it was also initiated to stimulate a discussion regarding areas in need of improvement.

          Related collections

          Author and article information

          Journal
          J. Lipid Res.
          Journal of lipid research
          American Society for Biochemistry & Molecular Biology (ASBMB)
          1539-7262
          0022-2275
          Dec 2017
          : 58
          : 12
          Affiliations
          [1 ] Marine Biochemical Sciences Group, Chemical Sciences Division, Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, SC john.bowden@nist.gov.
          [2 ] Statistical Engineering Division, National Institute of Standards and Technology, Gaithersburg, MD.
          [3 ] Marine Biochemical Sciences Group, Chemical Sciences Division, Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, SC.
          [4 ] Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.
          [5 ] The Roskamp Institute, Sarasota, FL.
          [6 ] Steno Diabetes Center Copenhagen, Gentofte, Denmark.
          [7 ] Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE.
          [8 ] Departments of Chemistry and Biochemistry and Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA.
          [9 ] Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA.
          [10 ] Department of Medicine, Harvard Medical School, Boston, MA.
          [11 ] Division of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka, Japan.
          [12 ] Division of Laboratory Sciences, Centers for Disease Control and Prevention, National Center for Environmental Health, Atlanta, GA.
          [13 ] Department of Chemistry-BMC, Analytical Chemistry, Uppsala University, Uppsala, Sweden.
          [14 ] University of Victoria-Genome British Columbia Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada.
          [15 ] Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
          [16 ] Gerald Bronfman Department of Oncology McGill University, Montreal, Quebec, Canada.
          [17 ] Proteomics Centre, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
          [18 ] Faculty of Medicine, Academic Unit of Clinical and Experimental Sciences, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.
          [19 ] National Institutes of Health West Coast Metabolomics Center, University of California Davis Genome Center, Davis, CA.
          [20 ] Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore and Singapore Lipidomic Incubator (SLING), Life Sciences Institute, Singapore.
          [21 ] Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
          [22 ] Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
          [23 ] Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
          [24 ] Biomarker Core Laboratory, Irving Institute for Clinical and Translational Research, Columbia University Medical Center, New York, NY.
          [25 ] Biochemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia.
          [26 ] Department of Pharmacology, New York Medical College School of Medicine, Valhalla, NY.
          [27 ] Thermo Fisher Scientific, San Jose, CA.
          [28 ] Department of Chemistry, Örebro University, Örebro, Sweden.
          [29 ] Metabolomics Core, BRCF, University of Michigan, Ann Arbor, MI.
          [30 ] Biocrates Life Sciences AG, Innsbruck, Austria.
          [31 ] Lipotype GmbH, Dresden, Germany.
          [32 ] Core Facility for Mass Spectrometry, Medical University of Graz, Graz, Austria.
          [33 ] Stable Isotope and Metabolomics Core Facility, Diabetes Research Center, Albert Einstein College of Medicine, Bronx, NY.
          [34 ] Analytical Facility of Bioactive Molecules, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
          [35 ] Lipidomics Core Facility and Department of Pathology, Wayne State University, Detroit, MI.
          [36 ] Department of Chemistry and Biochemistry, Concordia University, Montréal, Québec, Canada.
          [37 ] Proteomics and Metabolomics Shared Resource, Levine Science Research Center, Duke University School of Medicine, Durham, NC.
          [38 ] Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
          [39 ] Department of Biochemistry and Molecular Biology Medical University of South Carolina, Charleston, SC.
          [40 ] Chemical Sciences Division, Environmental Specimen Bank Group, Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, SC.
          [41 ] Departments of Medicine and Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA.
          [42 ] Division of Biology, Kansas Lipidomics Research Center, Kansas State University, Manhattan, KS.
          [43 ] Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
          [44 ] Hollings Marine Laboratory, Medical University of South Carolina, Charleston, SC.
          Article
          jlr.M079012
          10.1194/jlr.M079012
          5711491
          28986437
          94877fe0-4150-4486-af59-8ac208876d6f

          National Institute of Standards and Technology,sterols,quality control,Standard Reference Material 1950,phospholipids,fatty acyls,lipids,glycerolipids,sphingolipids,quantitation

          Comments

          Comment on this article